Ajay Samkaria/LinkedIn
Jun 9, 2026, 17:53
Ajay Samkaria: How ABO Subgroups Directly Impact Transfusion Safety
Ajay Samkaria, Product and Application Manager at DIAGAST, shared a post on LinkedIn:
“ABO subgroups are more than just laboratory curiosities—they are clinically significant and can directly impact transfusion safety.
Weak or variant antigen expressions may lead to blood grouping discrepancies, incompatible transfusions, and delayed clinical decisions if not properly identified.
Highlights:
- Classification of A, B and O subgroups.
- Bombay (Oh) and Para Bombay phenotypes.
- Rare phenotypes such as INA and INB.
- Clinical and immunohematological significance.
- Common methods for subgroup confirmation.
Accurate detection and confirmation of ABO subgroups remain essential for safe transfusion practice and quality immunohematology reporting.”
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 10:32Natalie Arnold: The Lp(a) Puzzle – Why Lower Levels May Not Tell the Whole Story
-
Nov 9, 2026, 10:22ISBT Opens Applications for the I TRY IT Programme 2027
-
Nov 9, 2026, 10:08Ibrahim Mansoor: Rare Tests, Common Diseases – Rethinking Autoimmune Diagnostics
-
Nov 9, 2026, 09:29Veronica Sanchez: A Framework for Woman’s Health
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services